Ginkgo Bioworks Inc.

NYSE: DNA · Real-Time Price · USD
12.89
-0.37 (-2.75%)
At close: Aug 14, 2025, 3:59 PM
13.09
1.51%
Pre-market: Aug 15, 2025, 09:21 AM EDT

Ginkgo Bioworks Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-0.93 -3.67 -1.35 -5.99
PEG Ratio
0.02 0.06 0.20 -0.00
PS Ratio
2.24 13.05 5.93 34.90
PB Ratio
0.71 2.99 1.63 7.28
P/FCF Ratio
-1.33 -9.75 -9.31 -35.3
P/OCF Ratio
-1.59 -11.1 -11.24 -43.16
OCF/S Ratio
-1.41 -1.18 -0.53 -0.81
Debt / Equity Ratio
0.65 0.22 0.25 0.02
Quick Ratio
5.62 6.11 8.36 12.76
Current Ratio
5.62 6.11 8.38 12.79
Asset Turnover
0.16 0.15 0.19 0.15
Interest Coverage
-5.95K -9.29K -20.84K -770.53
Return on Equity
-0.76 -0.81 -1.21 -1.22
Return on Assets
-0.4 -0.54 -0.83 -0.88
Return on Invested Capital
-0.42 -0.56 -0.9 -0.94
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.83 0.79 0.57 0.59
Net Profit Margin
-2.41 -3.55 -4.41 -5.83
Pretax Profit Margin
-2.41 -3.55 -4.44 -5.86
Operating Profit Margin
-2.47 -3.44 -4.62 -5.83
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-2.13 -3.27 -4.31 -5.76